SGD Pharma announces new CEO as it targets further growth
Worldwide glass primary packaging supplier SGD Pharma has announced the appointment of Olivier Rousseau as its new Chief Executive Officer. He brings over 30 years of industrial experience to the role, most recently after four years as CEO and President of Verallia France.
Prior to Verallia, Mr Rousseau worked for more than 20 years at The Goodyear Tire and Rubber Company, where his roles included Chief Financial Officer of the EMEA region, managing a portfolio worth €5 billion. After that, he led the consumer business unit for the EMEA region, managing a portfolio with a value of €3 billion.
Commenting on his appointment, Mr Rousseau said: “I am proud to join SGD Pharma and am looking forward to supporting the business at this exciting stage in its growth trajectory. I will continue to build on the strong foundation created by all members of the global SGD Pharma team in providing customers with high quality, innovative products to meet their changing demands, while improving our industrial performance across all plants. I have a strong interest in corporate social responsibility and decarbonization and as part of our proud sponsorship into the United Nations International Year of Glass, I will be continuing our initiatives into making glass products even more sustainable for society.”
Image: Olivier Rousseau is the new Chief Executive Officer of SGD Pharma.
